Wall Street’s Eyes Stay Glued to Vaccine Timeline

It's reported that Pfizer's vaccine is on schedule for regulatory review

Published: August 21, 2020

2 Clicks for Explosive Gains

How does the thought of locking-in virtually automatic deposits every seven days sound to you?


Soon you'll be able to access a brand-new method to earn weekly paydays from the market that are worth $3k-plus. 


Lance Ippolito is revealing the strategy that allows the little guy to cash in on certain stocks… just like the big banks do!


With just two clicks and five minutes a week, you could get thousands deposited into your account every seven days.

How you can join in

Roger Scott

20+ years of trading experience managed over $900 million teaching thousands daily.

Wall Street's Eyes Glued to Vaccine Timeline

Most global shares edged higher this morning on hopes for a virus vaccine, even though worries about the pandemic's long-term economic damage remain strong. 


It's reported that Pfizer's vaccine is on schedule for regulatory review in October, boosting investor sentiment. Additionally, a remark from China's Commerce Ministry that China and the U.S. will hold a meeting via a phone call "in the near future" to resolve their tariff war added to those levels. 


But how many times have we heard that…? 


In today's video, I've got more on the U.S.-China trade war tensions… why the housing market is so hot right now… the top sectors that are ripe for pullbacks… and two pullback opportunities on the fastest rising stocks. 


Get today's market action

S&P 500 Hits New Record High



August 19, 2020

Despite a fresh all-time high in the S&P 500, global markets are rather mixed this morning with European indexes opening little changed and U.S. futures somewhat lower. 


Continue Reading

Rally Backs Down on Fed Concerns



August 20, 2020

Global markets dropped this morning as minutes from the last Federal Reserve meeting exposed challenges facing the economy, as well as risks to the medium-term outlook. 


Continue Reading


Subscribe to receive free email updates:

0 Response to "Wall Street’s Eyes Stay Glued to Vaccine Timeline"

Post a Comment